Nosological reappraisal of primary cutaneous apocrine carcinoma based on a clinicopathological and genetic analysis of 30 cases
Histopathology · 2026-12 · 89 (6) · 975-989
DOI: 10.1111/his.70250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, online erschienen am 03.08.2026. Verfasst von Keisuke Goto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan. Hauptthemen laut MEDLINE: Sweat Gland Neoplasms, Apocrine Glands. Die Arbeit nennt 32 Literaturangaben. Gefördert von: OICI fund for Department of Diagnostic Pathology and Cytology in 2025.
Abstract (Originalsprache)
Aims
The nosology of primary cutaneous apocrine carcinoma remains controversial, as the term has often been used as a heterogeneous diagnostic category. The aim of this study was to clarify the clinicopathological and molecular features of strictly defined apocrine carcinoma using modified diagnostic criteria. Methods and results Thirty cases were collected from three institutions. Male predominance (28/30, 93%), predominance in elderly patients (median age, 72 years; range, 33–89 years) and the favourite site of the axilla (29/30, 97%) were observed. Lymph node and distant metastases occurred in 64% (16/25) and 28% (7/25) of cases, respectively. Two patients died of the disease (2/25, 8%), with a median follow‐up period of 2 years and 1 month. Histopathologically, all tumours harboured cytoplasmic zymogen‐like granules; however, some (8/30, 27%) lacked apocrine secretion features. Nucleoli were either moderately prominent ( n = 17) or prominent ( n = 13). Apocrine gland hyperplasia was identified in 5 (17%) of the 30 cases. Immunoexpression of androgen receptor, BerEP4, cytokeratin 7, GATA3 and GCDFP15 was observed in all tested cases. In contrast, BCL2, CEA, oestrogen receptor and progesterone receptors were negative in all tested cases. Only 13 cases underwent molecular studies. PIK3CA hotspot mutations were detected in 8 of the 13 cases. Panel sequencing revealed KMT2D ( MLL2/4 ) mutations in three cases, all of which have no PIK3CA mutations.
Conclusions
Primary cutaneous apocrine carcinoma is a distinct entity characterized by remarkably consistent clinical, cytopathological, immunohistochemical and molecular features.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
- Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
- Department of Diagnostic Pathology, Hyogo Cancer Center, Akashi, Japan.
- Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.
- Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto, Japan.
- Department of Diagnostic Pathology, Chutoen General Medical Center, Kakegawa, Japan.
ORCID-Profile: Keisuke Goto, Yoji Kukita, Toshihiro Takai, Kazuyoshi Kajimoto, Yukiko Kiniwa, Keiichiro Honma
Förderung
- OICI fund for Department of Diagnostic Pathology and Cytology in 2025
Zitieren
APA
Goto, K., Kukita, Y., Ohe, S., Hishima, T., Nishizawa, A., Takai, T., Kajimoto, K., Kiniwa, Y., & Honma, K. (2026). Nosological reappraisal of primary cutaneous apocrine carcinoma based on a clinicopathological and genetic analysis of 30 cases. Histopathology, 89(6), 975-989. https://doi.org/10.1111/his.70250
Vancouver
Goto K, Kukita Y, Ohe S, Hishima T, Nishizawa A, Takai T, et al. Nosological reappraisal of primary cutaneous apocrine carcinoma based on a clinicopathological and genetic analysis of 30 cases. Histopathology. 2026;89(6):975-989. doi:10.1111/his.70250
BibTeX
@article{Goto2026,
author = {Goto, Keisuke and Kukita, Yoji and Ohe, Shuichi and Hishima, Tsunekazu and Nishizawa, Aya and Takai, Toshihiro and Kajimoto, Kazuyoshi and Kiniwa, Yukiko and Honma, Keiichiro},
title = {Nosological reappraisal of primary cutaneous apocrine carcinoma based on a clinicopathological and genetic analysis of 30 cases},
journal = {Histopathology},
year = {2026},
volume = {89},
number = {6},
pages = {975--989},
doi = {10.1111/his.70250}
}
EUVIMED